Skip to content
Clinical Trials – home
FinlandBack to Finland

Clinical trials in Valkeakoski – page 16

281 clinical trials in Valkeakoski, Finland. Every trial is listed in the EU Clinical Trials Register and updated daily.

FinlandOur site in FinlandKliinisetTutkimukset.fi(opens in a new tab)
Valkeakoski at a glance
281
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

281 trials in Valkeakoski

Open in trial search

Yellow fever

Not recruiting

Study Comparing the Safety and Immune Response of the Investigational vYF Vaccine and Stamaril for Yellow Fever in Adults in Europe and Asia

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:18–64 years · Healthy volunteers
  • Substances:Yellow fever virus strain 17D-204 (live, attenuated)
  • Sponsor:Sanofi Pasteur

Safety and immunogenicity study of Pentavalent Meningococcal ABCYW vaccine (MenPenta SD and MenPenta fHD) compared to licensed meningococcal vaccines in infants, toddlers and children

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:0–17 years · Healthy volunteers
  • Substances:Diphtheria toxoid
  • Sponsor:Sanofi Pasteur Inc.

Study on the Safety and Immune Response of a 21-Valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:0–17 years · Healthy volunteers
  • Substances:Pneumococcal oligosaccharide serotype 18C conjugated to CRM197
  • Sponsor:Sanofi Pasteur Inc.
Countries:FinlandFinland
  • Participants:0–17 years · Healthy volunteers
  • Substances:Clesrovimab
  • Sponsor:Merck Sharp & Dohme LLC

Herpes zoster

Not recruiting

Study on Long-Term Effects and Safety of Herpes Zoster Vaccine with Recombinant Varicella Zoster Virus Glycoprotein E in Older Adults

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Recombinant Varicella Zoster Virus Glycoprotein E
  • Sponsor:GlaxoSmithKline Biologicals

Study on the Safety and Immune Response of PF-07831695 and a Drug Combination for Pneumococcal Infections in Healthy Toddlers Aged 12-15 Months

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:0–17 years · Healthy volunteers
  • Substances:PF-07831695
  • Sponsor:Pfizer Inc.

Study on the Safety and Immune Response of MenACYW Conjugate Vaccine Compared to a Drug Combination in Healthy Infants and Toddlers

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:0–17 years · Healthy volunteers
  • Substances:N. Meningitidis Group C (Strain C11) Polysaccharide (De-O-Acetylated) Conjugated To Tetanus Toxoid
  • Sponsor:Sanofi Pasteur

Influenza+1

Not recruiting

Study on the Effectiveness and Safety of OVX836 Vaccine for Preventing Influenza in Healthy Adults Aged 18-59

Registered drug
Countries:FinlandFinland
  • Participants:18–64 years · Healthy volunteers
  • Substances:Sodium Chloride
  • Sponsor:Osivax

Study on the Safety and Effectiveness of MK-1654 for Preventing Respiratory Syncytial Virus (RSV) in Healthy Pre-Term and Full-Term Infants

Registered drug
Countries:FinlandFinland
  • Participants:0–17 years · Healthy volunteers
  • Sponsor:Merck Sharp & Dohme LLC

Coeliac disease

Not recruiting

Study of TEV-53408 Safety and Effectiveness in Adults with Celiac Disease During Gluten Exposure

Investigational
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:TEV-53408
  • Sponsor:Teva Branded Pharmaceutical Products R&D LLC

Breast cancer+1

Not recruiting

Study of PF-07220060 and Letrozole for Adults with HR-Positive, HER2-Negative Advanced Breast Cancer Without Prior Treatment

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Abemaciclib
  • Sponsor:Pfizer Inc.

Study Comparing Elacestrant and Standard Endocrine Therapy for Patients with Early Breast Cancer at High Risk of Recurrence

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Stemline Therapeutics Inc.

Other cities in Finland

The busiest research cities in the country

All 28 cities in Finland

Clinical research in Valkeakoski

What the registry says about research in the country

01 Surgical Pain Management Research

Innovative research focusing on post-operative pain control for patients undergoing inguinal hernia surgery. The studies explore advanced regional anesthesia techniques to enhance recovery outcomes.

  • Regional Nerve Blocks
  • Post-Operative Recovery
  • Pain Management Protocols

Clinical investigations are evaluating the effectiveness of combined transversus abdominis plane and rectus sheath blocks compared to conventional approaches in surgical pain management.

02 Anesthesiology Advancements

Research examining innovative anesthetic block techniques for improved surgical outcomes. Studies focus on comparing different regional anesthesia methods to optimize patient comfort during recovery.

  • Anesthetic Efficacy
  • Block Technique Comparison
  • Patient Recovery Optimization

The research aims to establish evidence-based protocols for enhanced recovery after open hernia surgery through targeted nerve blocks.

03 Surgical Recovery Enhancement

Studies investigating methods to improve post-surgical recovery through advanced pain management strategies. The research evaluates combined anesthetic approaches for better patient outcomes.

  • Recovery Protocols
  • Pain Control Methods
  • Patient Comfort Optimization

Researchers are analyzing the benefits of multiple regional anesthesia techniques in enhancing the overall surgical experience and recovery process.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.